pharma-company /Medicinal products /Active ingredients

Rx · PZN 20214559

VYSRIBLI 60 mg solution for injection in a pre-filled syringe

German trade nameVYSRIBLI 60 mg Injektionslösung in einer Fertigspritze

Active ingredientDenosumabPharmaceutical formSolution for injection/infusion

Consistently available

9.6

out of 10

0510

Pharma availability index · 30 days · as of 01.08.2026


Storage temperature and transport temperature

Cold chain 2–8 °C

Highest known
purchase price (B2B)

~ €59

We deliver data-driven insights into pharmaceutical price levels and pricing structures across European markets, enabling Most Favoured Nation (MFN) assessments, international price benchmarking, and strategic market access analyses.

VYSRIBLI 60 mg solution for injection in a pre-filled syringe is consistently available through wholesale. We are happy to review your purchase price and advise you on it.

Review purchasing terms

VYSRIBLI 60 mg solution for injection in a pre-filled syringe contains the active ingredient Denosumab and comes as Solution for injection/infusion. One pack size is recorded (PZN 20214559). The pharma availability index for German wholesale stands at 9.6 out of 10 over the past 30 days – the pack was therefore consistently available.


We are happy to advise you on sources of supply, purchase prices and procurement optimisation for your pharmaceutical wholesale business or your pharmacy.

Get in touch

The pharma availability index is averaged from the data available to us. Purchase prices are rounded approximations in euros. One PZN is recorded for this product; the stated purchase price refers to it.